- Home
- DYN vs PSNY Comparison
DYN vs PSNY Comparison
Compare DYN & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- PSNY
- Stock Information
- Founded
- DYN 1984
- PSNY 2017
- Country
- DYN United States
- PSNY Sweden
- Employees
- DYN N/A
- PSNY N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- PSNY Auto Manufacturing
- Sector
- DYN Health Care
- PSNY Consumer Discretionary
- Exchange
- DYN Nasdaq
- PSNY Nasdaq
- Market Cap
- DYN 1.4B
- PSNY 2.4B
- IPO Year
- DYN 2020
- PSNY N/A
- Fundamental
- Price
- DYN $8.64
- PSNY $1.08
- Analyst Decision
- DYN Strong Buy
- PSNY Hold
- Analyst Count
- DYN 15
- PSNY 5
- Target Price
- DYN $43.60
- PSNY $1.26
- AVG Volume (30 Days)
- DYN 3.7M
- PSNY 3.7M
- Earning Date
- DYN 08-11-2025
- PSNY 08-28-2025
- Dividend Yield
- DYN N/A
- PSNY N/A
- EPS Growth
- DYN N/A
- PSNY N/A
- EPS
- DYN N/A
- PSNY N/A
- Revenue
- DYN N/A
- PSNY $2,034,261,000.00
- Revenue This Year
- DYN N/A
- PSNY $101.15
- Revenue Next Year
- DYN N/A
- PSNY $54.99
- P/E Ratio
- DYN N/A
- PSNY N/A
- Revenue Growth
- DYN N/A
- PSNY N/A
- 52 Week Low
- DYN $6.36
- PSNY $0.61
- 52 Week High
- DYN $47.45
- PSNY $1.94
- Technical
- Relative Strength Index (RSI)
- DYN 33.82
- PSNY 48.97
- Support Level
- DYN $8.06
- PSNY $1.07
- Resistance Level
- DYN $9.30
- PSNY $1.22
- Average True Range (ATR)
- DYN 0.58
- PSNY 0.07
- MACD
- DYN -0.13
- PSNY 0.00
- Stochastic Oscillator
- DYN 21.64
- PSNY 26.32
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.